SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001178913-18-000517
Filing Date
2018-02-13
Accepted
2018-02-13 16:10:46
Documents
1
Group Members
TAMARKIN MEDICAL INNOVATIONS LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G zk1821193.htm SC 13G 80003
  Complete submission text file 0001178913-18-000517.txt   81415
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Subject) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88525 | Film No.: 18603398
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 537 HAR HILA ST. MODIIN-MACCABIM-REUT L3 7179901
Business Address
Tamarkin Dov (Filed by) CIK: 0001631962 (see all company filings)

Type: SC 13G